Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma

논문상세정보
    • 저자 최유신 서석원
    • 제어번호 103611230
    • 학술지명 Yonsei medical journal
    • 권호사항 Vol. 58 No. 4 [ 2017 ]
    • 발행처 연세대학교의과대학
    • 발행처 URL http://www.eymj.org
    • 자료유형 학술저널
    • 수록면 737-742
    • 언어 English
    • 출판년도 2017
    • 등재정보 KCI등재
    • 소장기관 아주대학교 의학문헌정보센터
    • 판매처
    유사주제 논문( 0)

' Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma' 의 참고문헌

  • Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma
    Plessier A Liver Transpl 10 2 Suppl 1 S86-S90 [2004]
  • Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma
    Fujiyama S Oncology 62 Suppl 1 57-63 [2002]
  • Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004
    Bosetti C Hepatology 48 137-145 [2008]
  • Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival
    Llovet JM Hepatology 37 429-442 [2003]
  • Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients
    Weinmann A Liver Int 35 591-600 [2015]
  • Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging
    Yang T J Cancer Res Clin Oncol 138 1121-1129 [2012]
  • Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group
    Ishii M Am J Gastroenterol 95 1036-1040 [2000]
  • Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features
    Okusaka T Cancer 95 1931-1937 [2002]
  • Prospective validation of the Barcelona Clinic Liver Cancer staging system
    Cillo U J Hepatol 44 723-731 [2006]
  • Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma
    Toyoda H Clin Gastroenterol Hepatol 4 111-117 [2006]
  • Prognostic prediction in patients with hepatocellular carcinoma
    Sala M Semin Liver Dis 25 171-180 [2005]
  • New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy
    Chan SL J Clin Oncol 27 446-452 [2009]
  • Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients
    Okuda K Cancer 56 918-928 [1985]
  • Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma
    Sasaki A Cancer 103 299-306 [2005]
  • Management of hepatocellular carcinoma: an update
    Bruix J Hepatology 53 1020-1022 [2011]
  • Is it time to reconsider the BCLC/AASLD therapeutic flow-chart?
    Livraghi T J Surg Oncol 102 868-876 [2010]
  • Hepatic resection improved the long-term survival of patients with BCLC stage B hepatocellular carcinoma in Asia: a systematic review and meta-analysis
    Liu W J Gastrointest Surg 19 1271-1280 [2015]
  • Hepatic resection for hepatocellular carcinoma exceeding Milan criteria
    Delis SG Surg Oncol 19 200-207 [2010]
  • Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma
    Zhong JH Ann Surg 260 329-340 [2014]
  • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
  • Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization
    Zhong JH PLoS One 8 e68193- [2013]
  • Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
    Bruix J J Hepatol 35 421-430 [2001]
  • Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels
    Kang SH Eur J Gastroenterol Hepatol 24 849-856 [2012]
  • Barcelona clinic liver cancer stage B hepatocellular carcinoma:transarterial chemoembolization or hepatic resection?
    Jianyong L Medicine (Baltimore) 93 e180- [2014]
  • A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group
    Torzilli G Ann Surg 257 929-937 [2013]
  • A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
    Hepatology 28 751-755 [1998]
  • A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire
    Chevret S J Hepatol 31 133-141 [1999]
  • A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
    Cabibbo G Hepatology 51 1274-1283 [2010]
  • A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010- 2016
    Yu SJ Clin Mol Hepatol 22 7-17 [2016]